National Atomic Company Kazatomprom JSC (KZAP) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
3 Nov, 2026Executive summary
9M 2026 production and consolidated uranium sales increased YoY; realized prices also rose, while sales timing varied between consolidated and KAP-level deliveries.
2026 guidance was reiterated unchanged across production, sales, revenue, cash-cost and capital-expenditure ranges.
Uranium spot and long-term prices strengthened amid constrained spot availability and growing uncovered demand; market and policy developments remained significant.
Financial highlights
9M production rose 10% YoY to 20,508 tU on a 100% basis and 12% to 10,969 tU on an attributable basis.
9M consolidated U3O8 sales increased 10% YoY to 14,030 tU; KAP-level sales declined 7% to 10,303 tU, reflecting delivery schedules and customer requests.
9M consolidated average realized price rose 17% YoY to $73.51/lb; KAP average realized price increased 14% to $70.19/lb.
Outlook and guidance
2026 guidance remains unchanged: production 27,500–29,000 tU at 100% basis and 14,500–15,500 tU attributable; consolidated sales 19,500–20,500 tU.
Revenue guidance is KZT 2,100–2,200bn consolidated and KZT 1,900–2,000bn from consolidated uranium sales; actual results may vary with uranium prices and USD/KZT rates.
Cash-cost guidance: attributable C1 $25.50–27.00/lb and all-in sustaining cost $39.00–40.50/lb; mining-entity capex guidance is KZT 435–450bn.
Latest events from National Atomic Company Kazatomprom JSC
- Higher realized prices and raised sales guidance offset disciplined, lower production volumes.KZAP
H1 2023 - Higher uranium prices lifted FY2023 revenue as 2024 guidance targets increased output and investment.KZAP
H2 2023 - Revenue up 9% YoY, net profit down 9%, with higher costs and strong uranium leadership.KZAP
Q2 2026 - Production, sales, and realized prices increased in 1H2026 amid robust uranium market demand.KZAP
Q2 2026 TU - Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Revenue fell but operating profit and production rose, with strong liquidity and growth plans.KZAP
Q2 2025 - H1 revenue and net profit climbed; 2025 output plans were curtailed by supply constraints.KZAP
Q2 2024 - 2024 net profit nearly doubled on uranium price strength and one-off gains; 2025 outlook robust.KZAP
Q4 2024